Heart Attack

Dynocardia’s Direct Continuous Blood Pressure Monitoring Technology Receives Grant from NIH’s Commercialization Readiness Pilot ProgramDynocardia’s Direct Continuous Blood Pressure Monitoring Technology Receives Grant from NIH’s Commercialization Readiness Pilot Program

Dynocardia’s Direct Continuous Blood Pressure Monitoring Technology Receives Grant from NIH’s Commercialization Readiness Pilot Program

The grant, which is awarded to companies developing significantly impactful technologies with the potential to change clinical practice, will support…

9 months ago
New Study Finds Twin Health Treats Hypertension in Patients with Type 2 DiabetesNew Study Finds Twin Health Treats Hypertension in Patients with Type 2 Diabetes

New Study Finds Twin Health Treats Hypertension in Patients with Type 2 Diabetes

The digital twin AI platform helps patients safely eliminate blood pressure medications and sustain normal blood pressure MOUNTAIN VIEW, Calif.,…

9 months ago
Lexaria Updates Current GLP-1 MarketLexaria Updates Current GLP-1 Market

Lexaria Updates Current GLP-1 Market

KELOWNA, BC / ACCESSWIRE / October 8, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX) & (NASDAQ:LEXXW) (the "Company" or "Lexaria"), a…

9 months ago
Amwell expands clinical programs portfolio to include Hello Heart cardiovascular health risk management solutionAmwell expands clinical programs portfolio to include Hello Heart cardiovascular health risk management solution

Amwell expands clinical programs portfolio to include Hello Heart cardiovascular health risk management solution

Hello Heart selects Amwell platform to extend its reach across patient populationsBOSTON and MENLO PARK, Calif., Oct. 08, 2024 (GLOBE…

9 months ago
Imperial College London Study Finds Eko Health AI Predicts Patients With High Risk of Major Adverse Cardiac EventsImperial College London Study Finds Eko Health AI Predicts Patients With High Risk of Major Adverse Cardiac Events

Imperial College London Study Finds Eko Health AI Predicts Patients With High Risk of Major Adverse Cardiac Events

Patients identified with reduced ejection fraction using Eko Health AI were twice as likely to experience heart attacks, heart failure,…

9 months ago
The Rush for Non-Addictive Painkillers to Counter the Opioid Crisis Puts Two Companies Close to FDA DecisionsThe Rush for Non-Addictive Painkillers to Counter the Opioid Crisis Puts Two Companies Close to FDA Decisions

The Rush for Non-Addictive Painkillers to Counter the Opioid Crisis Puts Two Companies Close to FDA Decisions

This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding…

9 months ago
HeartX Cardiovascular Accelerator Announces Four Startup Companies Selected for the 2024 ProgramHeartX Cardiovascular Accelerator Announces Four Startup Companies Selected for the 2024 Program

HeartX Cardiovascular Accelerator Announces Four Startup Companies Selected for the 2024 Program

BENTONVILLE, Ark., Sept. 30, 2024 /PRNewswire/ -- HeartX, powered by HealthTech Arkansas and MedAxiom — along with numerous leading cardiology practices…

9 months ago
Mineralys Therapeutics Completes Target Enrollment in Pivotal Advance-HTN Trial of Lorundrostat for the Treatment of HypertensionMineralys Therapeutics Completes Target Enrollment in Pivotal Advance-HTN Trial of Lorundrostat for the Treatment of Hypertension

Mineralys Therapeutics Completes Target Enrollment in Pivotal Advance-HTN Trial of Lorundrostat for the Treatment of Hypertension

– On track to announce topline data in Q1 2025 – – Virtual KOL event scheduled on October 30th to…

9 months ago
Milestone Pharmaceuticals to Host Investor KOL EventMilestone Pharmaceuticals to Host Investor KOL Event

Milestone Pharmaceuticals to Host Investor KOL Event

Learnings from the Field: Managing PSVT and Studying AFib-RVR in the Community Setting Hosted 10 am ET, Tuesday, October 8,…

9 months ago